Trials that use: Risk difference
New to this method? Read the tutorial →
6,276 results
- Safety of 4CMenB Exposure During Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Safety of 4CMenB Exposure During Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02640677).
- Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals’ Boostrix™ Vaccine in Healthy Vietnamese Children: Complete Statistical AnalysisIndependent statistical analysis of Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6: Complete Statistical AnalysisIndependent statistical analysis of Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04084171).
- Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR: Complete Statistical AnalysisIndependent statistical analysis of Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to
- Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase: Complete Statistical AnalysisIndependent statistical analysis of Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement: Complete Statistical AnalysisIndependent statistical analysis of Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.: Complete Statistical AnalysisIndependent statistical analysis of Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.: primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety of Intravenous Apramycin in Adults: Complete Statistical AnalysisIndependent statistical analysis of Safety of Intravenous Apramycin in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05590728).
- Safety of Intravenous Neridronic Acid in CRPS: Complete Statistical AnalysisIndependent statistical analysis of Safety of Intravenous Neridronic Acid in CRPS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02972359).
- Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea: Complete Statistical AnalysisIndependent statistical analysis of Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea: primary endpoint results,…
- Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren’s Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety of Vitamin D Supplementation in Older Persons: Complete Statistical AnalysisIndependent statistical analysis of Safety of Vitamin D Supplementation in Older Persons: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00681590).
- Safety Study for an All-in-One Body and Personal Lubricant: Complete Statistical AnalysisIndependent statistical analysis of Safety Study for an All-in-One Body and Personal Lubricant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01189617).
- Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif: Complete Statistical AnalysisIndependent statistical analysis of Safety Study in Relapsing-remitting Multiple Sclerosis (RRMS) Patients Receiving Betaferon or Rebif: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01469156).
- Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of a Selective Cytopheretic Device (SCD) in Patients With Acute Renal Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of Albuterol Spiromax® in Subjects With Asthma: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Albuterol Spiromax® in Subjects With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01698320).
- Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Avastin Used as Adjunctive Therapy in Pterygium Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety Study of Cosmetic Tissue Augmentation in People of Color: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Cosmetic Tissue Augmentation in People of Color: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01147172).
- Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subjects 65 to 75 Years of Age: primary endpoint results, effect…
- Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777): Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Intravenous Ertapenem in Combination With Zidebactam (WCK 6777): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Kedbumin 25% Versus Normal Saline in the Treatment of Post-Surgical Hypovolemia in Pediatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of KPT-330 (Selinexor) in Patients With Advanced or Metastatic Solid Tumor Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008): Complete Statistical AnalysisIndependent statistical analysis of Safety Study of MK-8237 Treatment in House-Dust-Mite Allergic Adolescents (MK-8237-008): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01678807).
- Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts in Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of the Effects of Inhaled Fluticasone Furoate/GW642444 on the Hypothalamic-Pituitary-Adrenal (HPA) Axis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of VM202 to Treat Amyotrophic Lateral Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02039401).
- Safety Study of XP12B in Women With Menorrhagia: Complete Statistical AnalysisIndependent statistical analysis of Safety Study of XP12B in Women With Menorrhagia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00113568).
- Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose: Complete Statistical AnalysisIndependent statistical analysis of Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose: primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital: Complete Statistical AnalysisIndependent statistical analysis of Safety Study to Assess IV Zanamivir for Treatment of Influenza Infection in Patients Who Are in Hospital: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying Therapy: Complete Statistical AnalysisIndependent statistical analysis of Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosis Who Receive Ozanimod Compared to Non-Pegylated Interferon (IFN)-β or No Disease Modifying…
- Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos: Complete Statistical AnalysisIndependent statistical analysis of Safety Surveillance of Pneumococcal 13-valent Conjugate Vaccine Among Filipinos: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01396434).
- Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.: Complete Statistical AnalysisIndependent statistical analysis of Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.: primary endpoint results, effect estimate with confidence interval,…
- Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors: Complete Statistical AnalysisIndependent statistical analysis of Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants: Complete Statistical AnalysisIndependent statistical analysis of Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1: Complete Statistical AnalysisIndependent statistical analysis of Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults.: Complete Statistical AnalysisIndependent statistical analysis of Safety, Immunogenicity of RTS,S/AS02A, and RTS,S/AS01B Malaria Vaccines in Malaria-experienced Adults.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Malaria Transmission Season in Healthy African Adult Women of Childbearing Potential in Mali: Complete Statistical AnalysisIndependent statistical analysis of Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites (PfSPZ Vaccine) During Malaria Transmission Season in Healthy African Adult Women of Childbearing Potential in Mali:…
- Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008): Complete Statistical AnalysisIndependent statistical analysis of Safety, Pharmacodynamics, and Pharmacokinetics of Different Dosing Regimens of MK-8266 in Participants With Hypertension (MK-8266-008): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate: Complete Statistical AnalysisIndependent statistical analysis of Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00319228).
- Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB): Complete Statistical AnalysisIndependent statistical analysis of Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 in Mucopolysaccharidosis III, Type B (MPS IIIB): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411: Complete Statistical AnalysisIndependent statistical analysis of Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy Trial of BNT411: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04101357).
- Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17: Complete Statistical AnalysisIndependent statistical analysis of Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…